Feature | Breast Imaging | April 18, 2019 | By Greg Freiherr

How Risk Stratification Might Affect Women’s Health

Various factors should be considered when planning to screen for breast cancer

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer. Permission to publish provided by DenseBreast-info.org

When planning a screening program to detect the early signs of breast cancer, age is a major consideration. But it should not be the only one, said Diana Miglioretti, Ph.D., a biostatistics professor at the University of California, Davis.

In an April 5 presentation at the Society for Breast Imaging (SBI)/American College of Radiology (ACR) Breast Imaging Symposium in Hollywood, Fla., Miglioretti noted that several factors can strongly affect the development of breast cancer. If women are to be accurately stratified by risk, these factors should be considered, she said.

One of them is age. The biostatistics professor explained how age can influence the risk of breast cancer (the vast majority of breast cancers occur in women older than age 50, according to the breast cancer surveillance consortium, abbreviated as BCSC) — and what it means for screening with FFDM (full-field digital mammography) and DBT (digital breast mammography).

 

How Individual Women Can Calculate Risk

Much of the risk of developing breast cancer depends on multiple factors, which is why BCSC has come up with a breast cancer risk calculator. Miglioretti highlighted this calculator in her symposium presentation. The free-of-charge calculator is available on the web or as an iPhone-compatible app that can be downloaded. It calculates and compares a woman’s risk of cancer to that of the average woman.

“So if a woman has twice the average risk, she might consider more aggressive screening or start screening early,” Miglioretti said.

The calculator considers a woman’s:

  • Age (the risk of developing breast cancer increases with advancing age, according to the BCSC);
  • race and ethnicity (calibrated by BCSC for non-Hispanic white, non-Hispanic black, Asian/Native Hawaiian/Pacific Islander, Native American/Native Alaskan, and Hispanic women);
  • family history of breast cancer, marked by first-degree relatives — such as mother, sisters and daughters — who have had breast cancer;
  • history of breast biopsy (BCSC noted that risk especially increases if past biopsy specimens showed atypical ductal hyperplasia, a noncancerous condition in which the number of ductal cells increases or these cells look abnormal, or lobular carcinoma in situ, a noninvasive condition characterized by abnormal cells in breast lobules); and
  • breast density, which is determined by the relative amounts of fat, epithelial, and connective tissues that appear differently on mammograms due to X-ray attenuation, according to BCSC.

 

Why Considering Multiple Factors Makes Sense

Miglioretti noted that risk assessment is critically important to coming up with a personalized approach to screening, which she strongly advocates. The biggest benefit from breast cancer screening is early detection, she said, because when breast cancer is detected early, “you have more of a chance to prevent death and morbidity.“

But the chance of physical and psychological harm from screening should be considered. Either or both may result from false-positives, she said, noting that physical harm may come from unneeded chemotherapy or surgery. Psychological harm may occur when a woman thinks she has cancer but doesn’t, Miglioretti said.

The development of a personalized screening approach contrasts sharply with current guidelines, which rely heavily on a single factor, age. At least one guideline recommends that screening begin at age 50; others advise the start of screening much younger — one as early as age 40 (the American Cancer Society Guidelines for the Early Detection of Cancer.)

“But there are women in their 50s who are at lower risk than someone in their 40s,” she said. “Using a risk-based approach would actually identify more women with potential benefit from screening than using just age.”

Current guidelines may seem inconsistent because they recommend that screening start at different ages, Miglioretti said. But all guidelines say that women in their 40s should use personal choice to decide whether screening is right for them, she said: “We should empower women to make these decisions for themselves.”

Women, Miglioretti emphasized, should be encouraged to make their own choices about when to start screening and how aggressively to do so (whether annually or biannually, for example). Their decisions should be based on how they value the benefits versus harms, although some patients, she noted, may want to defer to their physicians.

“And that is fine as well,” she said. “Either way, it is the patient’s choice.”

 

Greg Freiherr is a contributing editor to Imaging Technology News (ITN). Over the past three decades, he has served as business and technology editor for publications in medical imaging, as well as consulted for vendors, professional organizations, academia, and financial institutions.

Related content:

VIDEO: Age, Interval and Other Considerations for Breast Screening

BOOK: Breast Cancer Screening: Making Sense of Complex and Evolving Evidence

 Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography

Risk Stratification for Screening Mammography: Benefits and Harms

VIDEO: A Discussion on Proposed FDA Rules for Mammography Reporting

FDA Proposes New Rules for Mammography Reporting and Quality Improvement

Related Content

The study found that DBN laws helped some women understand they had increased breast density, but not that breast density is associated with a higher risk of breast cancer or that dense breasts limit the ability of mammograms to detect cancer
News | Breast Density | January 09, 2020
January 9, 2020 — A new study suggests that state-mandated notifications on...
Sponsored Content | Videos | Digital Radiography (DR) | January 03, 2020
At RSNA19, David Widmann, president and CEO of Konica Minolta Healthcare Americas, discussed innovation, stressing th
Videos | MRI Breast | December 26, 2019
Gillian Newstead, M.D., director of global breast imaging and former professor at the University of Chicago, explains
Patient inclusion flowchart shows selection of women in the training and validation samples used for deep neural network development, as well as in the test sample (current study sample). Exclusions are detailed in the footnote. PACS = picture archiving and communication system. Image courtesy of Radiological Society of North America.

Patient inclusion flowchart shows selection of women in the training and validation samples used for deep neural network development, as well as in the test sample (current study sample). Exclusions are detailed in the footnote. PACS = picture archiving and communication system. Image courtesy of Radiological Society of North America.

News | Artificial Intelligence | December 18, 2019
December 17, 2019 — A sophisticated type of artif...
A new market report focuses on breast imaging devices, paying special attention to their recent emergence

Image courtesy of Eizo

News | Breast Imaging | December 17, 2019
December 17, 2019 — The ...
Researchers recently conducted the largest population-based long-term retrospective analysis of non-cancer causes of death among patients with breast cancer

Image courtesy of RSNA

News | Clinical Trials | December 17, 2019
December 16, 2019 — Survival rates for patients with breast cancer have improved significantly in the last four decad
Timothy Whelan is a professor of oncology at McMaster University and a radiation oncologist at the Juravinski Cancer Centre of Hamilton Health Sciences. He holds a Canada Research Chair in Breast Cancer Research. Photo courtesy McMaster University

Timothy Whelan is a professor of oncology at McMaster University and a radiation oncologist at the Juravinski Cancer Centre of Hamilton Health Sciences. He holds a Canada Research Chair in Breast Cancer Research. Photo courtesy McMaster University. Photo courtesy of McMaster University

News | Breast Imaging | December 06, 2019
December 6, 2019 — A shorter course of higher-dose radiation treatment to part of the breast is showing promise in wo
#RSNA19 GE Healthcare introduced Serena Bright, the healthcare industry’s first contrast-enhanced mammography solution for biopsy
News | Mammography | November 30, 2019
November 30, 2019 — To help empower clinicians and patients in their fight against...
This bar graph shows breast cancer presentation by screening interval #RSNA19

This bar graph shows breast cancer presentation by screening interval. Image courtesy of study author and RSNA

News | Breast Imaging | November 28, 2019
November 28, 2019 — Cancers found in patients undergoing annual...